The established anticancer and neuroprotective properties of oleocanthal combined with reported role of mammalian target of rapamycin (mTOR) in cancer and Alzheimers disease development encouraged us to examine the chance that oleocanthal inhibits mTOR. at low micromolar focus within a dose-dependent way. Oleocanthal treatment triggered a proclaimed downregulation of phosphorylated mTOR in metastatic breasts cancer… Continue reading The established anticancer and neuroprotective properties of oleocanthal combined with reported